Executive vice president, research and development · ZEVRA THERAPEUTICS, INC. (ZVRA)

Sven Guenther

A named executive officer of ZEVRA THERAPEUTICS in every fiscal year CompBrief holds from FY2017 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,082,153

Salary $398,982Stock awards $0

FY2020: $563,331

2nd of 4 named executive officers at Zevra Therapeutics by FY2021 total.

4 named officers on file for ZEVRA THERAPEUTICS, FY2021

Sven Guenther’s pay file — $29

  • 5 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ZEVRA THERAPEUTICS’s whole pay program stands against its peers

  • ZEVRA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZVRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 12, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Sven Guenther’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Sven Guenther compensation by year

ZEVRA THERAPEUTICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as ZEVRA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021
Salary$345,000$353,333$363,875$374,792$398,982
Bonus$0$0$0$10,000$0
Stock awards$0—$0—$0
Option awards$206,418$302,948$311,906$51,193$584,888
Non-equity incentive$65,688$0$0$124,285$85,022
Pension and deferred compensation$0$0$0—$0
All other$16,761$11,440$11,950$13,061$13,261
Total$633,867$693,606$687,731$563,331$1,082,153

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ZEVRA THERAPEUTICS, INC. DEF 14A filed May 12, 2022, accession 0001437749-22-012183, and prior-year filings.

How this page was built: the ZEVRA THERAPEUTICS, INC. filed document, accession 0001437749-22-012183. Every figure is read from that document and cited to the page and table it appears in. Filed May 12, 2022.

$634K
$694K
$688K
$563K
$1.1M
FY17
FY18
FY19
FY20
FY21
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option81,716—$9.06
Option1,172—$88.00
Option5,000—$42.56

Per the Outstanding Equity Awards at Fiscal Year-End table in ZEVRA THERAPEUTICS, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2021 proxy (filed May 12, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-01-31Grant or award derivative—79,000$0.0079,000

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ZEVRA THERAPEUTICS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Travis MicklePresident, chief executive officer and director$2,657,059
Sven Guenther · this pageExecutive vice president, research and development$1,082,153
R. LaDuane CliftonChief financial officer, secretary and treasurer$1,056,212
Richard PascoeExecutive chairman$712,482

The full ZEVRA THERAPEUTICS compensation record

free company brief

This page is one person within ZEVRA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ZEVRA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sven Guenther's compensation dossier · One-time report. No refunds.